GLENN SBLENDORIO
CIK 1277478 · Chief Executive Officer · last filed 2026-06-18
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$169.8K
Companies
7
Total Filings
146
Lifetime Open-Market Net
-$22.97M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| FDMT | Director | — | $11.14 | — | $0 | 2 | 2026-06-18 |
| AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Director | 0 | $14.49 | $0 | -$412.0K | 26 | 2026-04-27 |
| MLYS | Director | 6,200 | $27.38 | $169.8K | $0 | 4 | 2026-02-20 |
| IVERIC bio, Inc. (ISEE) Delisted | Chief Executive Officer | 239,275 | $39.95 | $9.56M | -$5.06M | 25 | 2023-06-26 |
| INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Director | 31,558 | $19.00 | $599.6K | $0 | 10 | 2023-05-25 |
| IVERIC bio, Inc. (OPHT) Delisted | President and CEO | 68,105 | — | — | -$484.2K | 16 | 2019-04-03 |
| MEDICINES CO /DE (MDCO) Delisted | President & CFO | 99,805 | — | — | -$17.01M | 61 | 2015-09-04 |
Recent Filings · Page 3 of 15
146 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-12-13 | IVERIC bio, Inc. (ISEE) Delisted | Exer (M) | +46,700 | $0 | EDGAR |
| 2022-11-04 | IVERIC bio, Inc. (ISEE) Delisted | Sell (S) | −50,000 | -$1.15M | EDGAR |
| 2022-06-10 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Grant (A) | +12,671 | $0 | EDGAR |
| 2022-05-27 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Grant (A) | +7,737 | $0 | EDGAR |
| 2022-04-06 | IVERIC bio, Inc. (ISEE) Delisted | Sell (S) | −50,000 | -$937.8K | EDGAR |
| 2022-04-01 | IVERIC bio, Inc. (ISEE) Delisted | Mixed | — | -$630.2K | EDGAR |
| 2022-03-29 | IVERIC bio, Inc. (ISEE) Delisted | Mixed | — | -$265.1K | EDGAR |
| 2022-03-22 | IVERIC bio, Inc. (ISEE) Delisted | Mixed | — | -$48.9K | EDGAR |
| 2022-03-07 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Exer (M) | +15,000 | $71.8K | EDGAR |
| 2022-01-03 | IVERIC bio, Inc. (ISEE) Delisted | Mixed | — | -$12.7K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.